Structure-Function and Biochemical Analysis of Tau
Principal Investigator
Stuart Feinstein, PhD
University of California, Santa Barbara
Santa Barbara, CA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 1995 - March 31, 1996
Grant ID
A1995037
Summary
One of the major disease related features of the brains of people with Alzheimer’s Disease is neurofibrillary tangles. Neurofibrillary tangles are insoluble aggregates that fill Alzheimer’s neurons, and are almost entirely of a single protein called tau. Tau is a protein that is produced in healthy brains where it is involved in the regulation of the architecture of nerve cells by interacting with another protein known as tubulin. Somehow tau’s structure becomes altered in Alzheimer’s disease. Abnormal tau interacts differently with tubulin, and tau becomes a major contributor if not the cause of pathology in Alzheimer’s disease by forming NFTs. We will use techniques of molecular biology and X-ray crystallography to learn more about the differences between normal and abnormal tau. We can divide the tau protein into functional pieces that we can study separately. With X-ray crystallography we can determine what these pieces look like in both their normal and abnormal forms. To do this we must crystallize the tau fragments, which is the major work we propose to do with research funds from the AHAF. We will also look more closely at the interaction between tau and tubulin in order to determine the best way to proceed with the study by crystallography of the tau – tubulin interaction. We hope that knowing what tau looks like will give us ideas about how to inhibit the change from the normal to the diseased state.
Related Grants
Alzheimer's Disease Research
The Role of JADE1 in Tauopathy
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Marcos Schaan Profes, PhD
Current Organization
Icahn School of Medicine at Mount Sinai
The Role of JADE1 in Tauopathy
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Marcos Schaan Profes, PhD
Current Organization
Icahn School of Medicine at Mount Sinai
Alzheimer's Disease Research
Harnessing the Protein CHIP/STUB1 to Reduce Alzheimer's Brain Pathology
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Todd Cohen, PhD
Current Organization
The University of North Carolina at Chapel Hill
Harnessing the Protein CHIP/STUB1 to Reduce Alzheimer's Brain Pathology
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Todd Cohen, PhD
Current Organization
The University of North Carolina at Chapel Hill
Alzheimer's Disease Research
Unlocking Tau’s Secrets: Human Brain Cells in the Mouse Brain
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Wenhui Qu, PhD
Current Organization
Weill Medical College of Cornell University
Unlocking Tau’s Secrets: Human Brain Cells in the Mouse Brain
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Wenhui Qu, PhD
Current Organization
Weill Medical College of Cornell University